Mechanism and consequences of the shift in cardiac arginine metabolism following ischaemia and reperfusion in rats

Thrombosis and Haemostasis

Volumn 113, Issue 3, 2015, Pages 482-493

  Schreckenberg, Rolf ^a   Weber, Pia ^a   Cabrera Fuentes, Hector A ^a,e   Steinert, Isabel ^a   Preissner, Klaus T ^a   Bencsik, Péter ^b   Sárközy, Márta ^c   Csonka, Csaba ^b,c   Ferdinandy, Péter ^b,d   Schulz, Rainer ^a   Schlüter, Klaus Dieter ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b PHARMAHUNGARY GROUP   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e KAZAN FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGINASE 1; ARGININE; ATRIAL NATRIURETIC FACTOR; CAPTOPRIL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; MESSENGER RNA; NITRIC OXIDE; NOR NOHA; ORNITHINE DECARBOXYLASE; POLYAMINE; PROTEIN BAX; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SUPEROXIDE; TAPI; TROPOMYOSIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR; UNCLASSIFIED DRUG; ADAM PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; GENE EXPRESSION; HEART FUNCTION; HEART MUSCLE METABOLISM; IN VIVO STUDY; ISCHEMIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSTHORACIC ECHOCARDIOGRAPHY; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CONVALESCENCE; DISEASE MODEL; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; ISOLATED HEART; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; TIME;

ADAM PROTEINS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ARGINASE; ARGININE; CAPTOPRIL; DISEASE MODELS, ANIMAL; ISOLATED HEART PREPARATION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE; POLYAMINES; RATS; RECOVERY OF FUNCTION; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT;

EID: 84924106106     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-05-0477     Document Type: Article

References (32)

1. Goel K, Pinto DS, Gibson M. Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: A systematic review. Am Heart J 2013; 165: 451–467.
2. Brodie BR, Stone GW, Cox DA, et al.. Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: Analysis from the CADILLAC trial. Am Heart J 2006; 151: 1231–1238.
3. Schoemaker RG, Debets JJM, Struyker-Boudier HAJ, et al. Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction. J Mol Cell Cardiol 1991; 23: 187–197.
4. Litwin SE, Litwin CM, Raya TE, et al. Contractility and stiffness of noninfarcted myocardium after coronary ligation in rats. Effects of chronic angiotensin converting enzyme inhibition. Circulation 1991; 83: 1028–1037.
5. Pfeffer MA, Pfeffer JM, Steinberg C, et al. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 1985; 72: 406–412.
6. Youn TJ, Kim HS, Oh BH. Ventricular remodelling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade. Basic Res Cardiol 1999; 94: 246–253.
7. Kingma JH, van Gilst WH, Peels CH, et al. Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction. Eur Heart J 1994; 15: 898–907.
8. Divisova J, Vavrinkova H, Tutterova M, et al. Effect of ACE inhibitor captopril and L-arginine on the metabolism and on ischaemia-reperfusion injury of the isolated rat heart. Physiol Res 2001; 50: 143–152.
9. Jugdutt BI. Nitric oxide and cardioprotection during ischaemia-reperfusion. Heart Failure Reviews 2002; 7: 391–405.
10. Ferdinandy P, Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 2003; 138: 532–543.
11. Csonka C, Szilvássy Z, Fülöp F, et al. Classic preconditioning decreases the harmful accumulation of nitric oxide during ischaemia and reperfusion in rat hearts. Circulation 1999; 100: 2260–2266.
12. Hein TW, Zhang C, Wang W, et al. Ischaemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. FASEB J 2003; doi 10.1096/fj.03–0115fje.
13. Sodha, NR, Boodhwani M, Clements RT, et al. Coronary microvascular dysfunction in the setting of chronic ischaemia is independent of arginase activity. Microvascular Res 2008; 75: 238–146.
14. Tabor CW, Tabor H. 1, 4-Diaminobutane (putrescine), spermidine, spermine. Ann Rev Biochem 1976; 45: 285–306.
15. Giordano E, Flamigni F, Guarnieri C, et al. Poylamines in cardiac physiology and disease. Open Heart Failure Journal 2010; 3: 25–30.
16. Schlüter K–D, Frischkopf K, Flesch M, et al. Central role for ornithine decarboxylase in b-adrenoceptor mediated hypertrophy. Cardiovasc Res 2000; 45: 410–417.
17. Shimizu M, Irimajiri O, Nkano T, et al. Yamada H, Sasaki H, Isogai Y. Effect of captopril on isoproterenol-induced myocardial ornithine decarboxylase activity. J Mol Cell Cardiol 1991; 23: 665–670.
18. Jung C, Gonon AT, Sjoquist PO, et al. Arginase inhibition mediates cardiac protection during ischaemia-reperfusion. Cardiovasc Res 2010; 85: 147–154.
19. Fischer S, Grantzow T, Pagel JI, et al. Extracellular RNA promotes leukocyte recruitment in the vascular system by mobilising proinflammatory cytokines. Thromb Haemost11 2012; 108: 730–741.
20. Harpster MH, Bandyopadhyay S, Thomas P, et al. Earliest changes in the left ventricular transcriptosome post-myocardial infarction. Mammalian Genome 2006; 17: 701–715.
21. Gao X, Xu X, Belmadini S, et al. TNF-a contributes to endothelial dysfunction by upregulating arginase in ischaemia/reperfusion injury. Arterioscler Thromb Vasc Biol 2007; 27: 1269–1275.
22. Zhang C, Wu J, Xu X, et al. Potter BJ, Gao X. Direct relationship between levels of TNF-b expression and endothelial dysfunction in reperfusion injury. Basic Res Cardiol 2010; 105: 453–464.
23. Frascarelli S, Ghelardoni S, Ronca-Tzestoni S, et al. Cardioprotective effect of zofenopril in perfused rat hearts subjected to ischaemia and reperfusion. J Cardiovasc Pharmacol 2004; 43: 294–299.
24. Bencsik P, Kupai K, Giricz Z, et al. Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signalling in myocardial late preconditioning in rats. Am J Physiol Heart Circ Physiol 2010; 299: H512-H518.
25. Da Costa Rebelo RM, Schreckenberg R, Schlüter K–D. Adverse cardiac remodelling in spontaneously hypertensive rats: acceleration by high aerobic exercise intensity. J Physiol 2012; 590: 5389–5400.
26. Kocsis GF, Sárközy M, Bencsik P, et al. Preconditioning protects the heart in a prolonged uremic condition. Am J Physiol Heart Circ Physiol 2012; 303: H1229–1236.
27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-DDCT). Methods 2001; 25: 402–408.
28. Maxeiner H, Krehbiel N, Müller A, et al. New insights into paracrine mechanisms of human cardiac progenitor cells. Eur J Heart Fail 2010; 12: 730–737.
29. Canton M, Skyschally A, Menabo R, et al. Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolisation. Eur Heart J 2006; 27: 875–881.
30. Deignan JL, Livesay JC, Shantz LM, et al. Polyamine homeostasis in arginase knockout mice. Am J Physiol Cell Physiol 2007; 293: C1296-C1301.
31. Flesch M, Höper A, Dell’Italia L., et al. Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2003; 108: 598–604.
32. Mörlein C, Schreckenberg R, Schlüter K–D. Basal ornithine decarboxylase activity modifies apoptotic and hypertrophic marker expression in post-ischaemic hearts. Open Heart Failure J 2010; 3: 31–37.